{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:681",
      "entity_text" : "dopamine",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01528",
      "entity_text" : "RO5166017",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "For example, Revel et al XREF_BIBR showed that the TAAR1 agonist RO5166017 inhibited the firing frequency of dopamine and serotonin neurons in regions where TAAR1 is expressed (eg, VTA and dorsal raphe nucleus) and blocked dopamine dependent hyperlocomotion in cocaine treated mice and DAT knockout mice as well as hyperactivity induced by an NMDA antagonist.",
  "reading_complete" : "2020-08-05T20:04:42Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T20:01:08Z",
  "trigger" : "inhibited",
  "evidence" : [ "RO5166017 inhibited the firing frequency of dopamine" ],
  "pmc_id" : "3682756",
  "score" : 0
}